Illumina Inc (NASDAQ:ILMN)

Illumina is a Stock Advisor pick that happens to be a local company here in San Diego. I always like it when a company makes something that other compnanies need to do business and the life science community here is vibrant, to say the least.
Good future here despite patent disputes in this industry which are a fact of life.

What a gift to give to your kids for Christmas--their very own genome. This is better than a car!

Illumina may temporarily rise, but will continue to muddle along until increased NIH funding arrives. This will be a cyclical stock based on governmental funds. The fact that this is a very competitive industry with light-year sized jumps in technology also makes companies in this area risky. However, the fact that universities continually have to update their sequencers means that there will be a strong demand when funds are available.

There are currently 1410 ILMN shares in my "fund" with break-even of around 41.38 USD. http://caps.fool.com/Blogs/fund-trades/678775.

"It appears that production got ahead of demand, though we won't know more about this until the company releases results later this month."

This is exactly what happens with Boom and Bust cycles. What the Fed did in 2009 to stimulate the economy caused a lot of companies to invest in longer term production and now with the end of QE there is a lot of downsizing a liquidation. Investors don't know which companies will survive liquidation and which will go bust, so they are pulling a lot of their money out of the market.

ILMN with their connection to research and academia is the typical company to which stimulus dollars went. I know because I am connected to academia and I work on research, and I saw a lot of scrambling then to hire and increase capacity in order to spend stimulus dollars. Now the stimuls is gone and the economy is not growing. Add to that the coming cuts and you have a recipe for liquidation.

So the main question is the following. What is ILMN's ability to adapt, liquidate and downsize? That depends in how much debt they have and how much cash they have. If you can answer these questions, you will know if this is a hold or a sell.

Put in this category all the alternative energy companies. The ones making solar panels, bateries, windmills, etc.

Been around forever.Gleason knew exactly what he
doing..............great body of work, staff, band, A1 .

Initiate 1/4 position

Yooperking pick and Oxford Club recommendation that looks good.

The next big thing

One of a kind technology creates demand and growth.

Even if it never climbs back to where it was before the huge drop earlier, it should still prove successful over the long term.

Company will profit greatly from increased interest in genomic mapping for various diseases and looking at protein interactions with the genome. Beginning to be the new big thing in research and with a high quality reputation.

Powerful sequencing technology.

Good 3 Yr EPS & Revenue Growth.

This is a small/mid cap high growth stock that should outperform the S&P during the bull market.

to high

DNA sequencing is moving into mainstream pharma, and Illumina has the market share and technology. They will dominate for the foreseeable future a fast, fast growing market. The Intel of biotech.

Next generation sequencing is changing the field of Genetics. Look for the technology to move from the research market to the clinical market in the next 2-5 years. This will led to 20%+ growth of the market for many years. Illumina is the clear leader in the field, good margins, good earnings growth.

stock advisor buy now and high ibd score